ligand (FML) antigen of Leishmania donovani in formulation with QuilA saponin. The 100%
of vaccinees were seropositive to FML and showed intradermal reaction to L. donovani
lysate, 2 months after vaccination. The absorbency values and size of intradermal reaction
were both significantly higher in vaccinees than in controls along a 3.5 years period
(ANOVA, P< 0.0001). The 25% of the control animals (two dogs on the first year and six dogs …